Table I.

Patients' Characteristics

HLA-B7 status
PatientGenderAgeFACS®SequenceTime since
 HIV detectionCD4 countaViral loadbDuration
 of ARTTreatmentc
yrcells/mlyr
1M42++4491<504d4T-ddI-NEV
2M33++96421,77653TC-d4T-NEV
3M54++2.5446<502.5AZT/3TC
4M41++1046353,3629AZT/3TC-RIT-SAQ
5M49++1661618,81515d4T-ddI-NEV
6F47+ND1460320,42711d4T-3TC
7M58++2.586611,4820none
8M47+ND1028922,38363TC-d4T-IND
10M33119011737d4T-3TC
  • a Peripheral CD4+ T lymphocyte count at the time of study.

  • b Copies of HIV-1 RNA per milliliter of plasma at the time of study.

  • c Treatment at the time of the study.

  • d4T, stavudine; ddI, didanosine; NEV, nevirapine; 3TC, lamivudine; AZT, zidovudine; RIT, ritonavir; SAQ, saquinavir; IND, indinavir; ART, antiretroviral therapy.